Gene: SIK3
Official Full Name: SIK family kinase 3provided by HGNC
Gene Summary: Enables ATP binding activity; magnesium ion binding activity; and protein serine/threonine kinase activity. Involved in positive regulation of TORC1 signaling; positive regulation of TORC2 signaling; and protein phosphorylation. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO29325 | SIK3 Knockout cell line (HeLa) | Human | SIK3 | 1:3~1:6 | Negative | Online Inquiry |
KO29326 | SIK3 Knockout cell line (HCT 116) | Human | SIK3 | 1:2~1:4 | Negative | Online Inquiry |
KO29327 | SIK3 Knockout cell line (HEK293) | Human | SIK3 | 1:3~1:6 | Negative | Online Inquiry |
KO29328 | SIK3 Knockout cell line (A549) | Human | SIK3 | 1:3~1:4 | Negative | Online Inquiry |
SIK3 Gene Knockout Cell Lines are specifically engineered cellular models lacking the SIK3 gene, which encodes the serine/threonine protein kinase SIK3, integral in regulating various cellular processes, including metabolism, stress response, and cell cycle progression. By utilizing CRISPR/Cas9 technology for precise genome editing, these cell lines facilitate the study of SIK3's role in cellular physiology, making them an invaluable resource for understanding its contributions to various pathological conditions.
The primary mechanism of these knockout cell lines is through the complete disruption of the SIK3 gene, leading to the absence of its protein product. This allows researchers to investigate the downstream effects of SIK3 deletion on signaling pathways, gene expression, and metabolic activities, thus shedding light on its role in diseases such as cancer and diabetes. The ability to simulate SIK3 deficiency opens channels for elucidating the mechanistic bases of its biological effects, paving the way for the development of targeted therapies.
In research and clinical settings, SIK3 Gene Knockout Cell Lines hold significant scientific importance as they provide a model system to assess barrier functions, metabolic pathways, and stress responses without the confounding effects of the SIK3 protein. They offer a reliable platform for drug discovery and development where the therapeutic potential of targeting SIK3 can be systematically explored.
Compared to traditional methods such as chemical inhibitors or RNA interference, our knockout cell lines provide a more sustainable and specific approach, mitigating off-target effects commonly associated with these alternatives. This specificity enhances experimental reproducibility and increases the validity of research findings.
For researchers and clinicians aiming to deepen their understanding of SIK3's biological functions and its implications in disease mechanisms, the SIK3 Gene Knockout Cell Lines represent a critical tool that allows for impactful exploration and discovery. Our company specializes in providing high-quality biological products designed for innovative research, ensuring that our offerings meet rigorous scientific standards and cater to the evolving needs of the scientific community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.